Citations

Showing 10 of 108094 citations.

Clinical and demographic predictors of survival for fibrolamellar carcinoma patients—A patient community, registry‐based study
Berkovitz, Amichai, Migler, Rachael D. , Qureshi, Adam , Rosemore, Carly, Vaughan, Roger , Marcotte, Erin L. , Simon, Sanford M. , Simon, Sanford M , Migler, Rachael D , Torbenson, Michael , Vaughan, Roger

Mayo Clinic

Hepatology Communications | October 17, 2022 | Volume: 6 | Issue: 12 | Pages: 3539-3549

10.1002/hep4.2105 | PMID 36245434 Get It

Abstract Fibrolamellar hepatocellular carcinoma (FLC) is a rare primary liver cancer that affects primarily adolescents and young adults. It is associated with a poor overall prognosis. There is a need to better define risk factors, but small sample size has limited such studies. An FLC patient registry now provides data sufficient for statistically robust inferences. We leveraged a unique patient community–based FLC registry to analyze the prognostic impact of demographic and clinical characteristics evident at diagnosis. Variables were analyzed using Cox proportional hazards regression to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). In multivariable models of 149 patients (88 females and 61 males), female gender was associated with statistically significant improved survival with HR of 0.52 (95% CI 0.29–0.93). Factors evident at diagnosis that are associated with worse survival included the presence of 10 or more tumors within the liver (HR 7.1; 95% CI 2.4–21.04), and metastases at diagnosis (HR 2.17; 95% CI 1.19–3.94). Positive lymph nodes at diagnosis, despite being found significantly associated with worse survival in a univariate analysis, did not remain significant when adjusted for covariates in a multivariable analysis. We found no statistically significant effect of age at diagnosis nor tumor size at diagnosis on survival. Female gender may confer a favorable prognosis in FLC. Established high‐risk prognostic factors that we confirmed in this Registry included the diagnostic presence of numerous intrahepatic tumors, and metastases. This is the first study derived from a FLC patient community–based registry, and highlights how registries of rare tumors can empower patients to meaningfully advance clinical and scientific discoveries.
Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriers
McKenna, Danielle , Sanchez, Pauleen, Powers, Jacquelyn , Brower, Jamie , Wang, Louise , Mueller, Rebecca , Symecko, Heather , Hamilton, Jada G. , Wildman, Temima , Offit, Kenneth , McKenna, Danielle B , Katona, Bryson W , Domchek, Susan M. , Couch, Fergus J. , Garber, Judy E. , Robson, Mark E.

Mayo Clinic

Journal of Genetic Counseling | October 17, 2022 | Volume: 32 | Issue: 2 | Pages: 342-350

10.1002/jgc4.1641 | PMID 36245263 Get It

AbstractGermline genetic testing for inherited cancer risk is increasingly being performed with multigene panel testing with MUTYH often included on colorectal cancer‐ and polyposis‐focused panels, as well as on broader pan‐cancer panels. With up to 1%–2% of the general population being monoallelic MUTYH carriers, pathogenic/likely pathogenic (P/LP) variants in MUTYH are one of the most common findings on multigene cancer panels. However, little is known about patient experience and understanding of monoallelic MUTYH P/LP variants, nor whether such findings influence medical management recommendations and familial communication, which this study aims to better understand. Monoallelic P/LP MUTYH carriers were recruited from the Prospective Registry of Multiplex Testing (PROMPT) and completed a cross‐sectional self‐report survey on sociodemographic characteristics, medical and family history, experiences with MUTYH genetic testing, genetics and MUTYH knowledge, perceived cancer risk, and familial communication. Of 115 eligible PROMPT participants, 49 (43%) completed the survey who were primarily female (94%), white (96%), had a history of cancer (61%), and a median age of 51.4 years. Most participants (61%) reported satisfaction with how their healthcare provider managed their genetic test result and care, and 65% of survey participants reported their provider recommended colonoscopy based on their genetic test results. Participants' responses also reflected variable levels of knowledge regarding cancer risks and screening recommendations for MUTYH carriers. The majority (98%) of participants shared their genetic test results with at least some of their relatives; however, only 13% of eligible relatives reportedly underwent cascade testing. Taken together, this study provides needed insight into the overall experiences of monoallelic MUTYH carriers and highlights numerous areas for improvement in clinician education, communication, and management of these individuals.
Cardiac Magnetic Resonance Imaging is a Promising Modality for Left Atrial Appendage Occlusion Planning
Deshmukh, Abhishek , Ward, Robert C.

Mayo Clinic

No container title available | October 17, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.166599419.92376992/v1 Get It

The preprocedural imaging before the left atrial appendage closure device is critical for selecting the appropriate device for the appropriate patient. CT scans and TEE have been used in the past for preprocedural imaging. In this report, the authors used cardiac MRI as a pre procedural planning tool in the wake of scarcity of contrast availability.
A Six-Week Follow-Up Study on the Sustained Effects of Prolonged Water-Only Fasting and Refeeding on Markers of Cardiometabolic Risk
Gabriel, Sahmla , Ncube, Mackson, Zeiler, Evelyn , Thompson, Natasha , Karlsen, Micaela, Goldman, David , Glavas, Zrinka, Beauchesne, Andrew R. , Scharf, Eugene , Goldhamer, Alan , Myers, Toshia R. , Karlsen, Micaela , Goldhamer, Alan C , Scharf, Eugene L , Karlsen, Micaela C

Mayo Clinic

Nutrients | October 17, 2022 | Volume: 14 | Issue: 20 | Pages: 4313

10.3390/nu14204313 | PMID 36296997 Get It

(1) Background: Chronic inflammation and insulin resistance are associated with cardiometabolic diseases, such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease. Therapeutic water-only fasting and whole-plant-food refeeding was previously shown to improve markers of cardiometabolic risk and may be an effective preventative treatment but sustained outcomes are unknown. We conducted a single-arm, open-label, observational study with a six-week post-treatment follow-up visit to assess the effects of water-only fasting and refeeding on markers of cardiometabolic risk. (2) Methods: Patients who had voluntarily elected and were approved to complete a water-only fast were recruited from a single-center residential medical facility. The primary endpoint was to describe changes to Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) scores between the end-of-refeed visit and the six-week follow-up visit. Additionally, we report on changes in anthropometric measures, blood lipids, high-sensitivity C-reactive protein (hsCRP), and fatty liver index (FLI). Observations were made at baseline, end-of-fast (EOF), end-of-refeed (EOR), and six-week follow-up (FU). (3) Results: The study enrolled 40 overweight/obese non-diabetic participants, of which 33 completed the full study protocol. Median fasting, refeeding, and follow-up lengths were 14, 6, and 45 days, respectively. At the FU visit, body weight (BW), body mass index (BMI), abdominal circumference (AC), systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), low-density lipoprotein (LDL), hsCRP, and FLI were significantly decreased from baseline. Triglycerides (TG) and HOMA-IR scores, which had increased at EOR, returned to baseline values at the FU visit. (4) Conclusion: Water-only fasting and whole-plant-food refeeding demonstrate potential for long-term improvements in markers of cardiovascular risk including BW, BMI, AC, SBP, DBP, blood lipids, FLI, and hsCRP.
Machine Learning and Deep Learning in Cardiothoracic Imaging: A Scoping Review
Khosravi, Bardia , Faghani, Shahriar , Moassefi, Mana, Vahdati, Sanaz , Mahmoudi, Elham , Chalian, Hamid , Erickson, Bradley J. , Faghani, Shahriar , Mahmoudi, Elham , Chalian, Hamid , Erickson, Bradley J , Khosravi, Bardia , Rouzrokh, Pouria , Moassefi, Mana

Mayo Clinic

Diagnostics | October 17, 2022 | Volume: 12 | Issue: 10 | Pages: 2512

10.3390/diagnostics12102512 | PMID 36292201 Get It

Machine-learning (ML) and deep-learning (DL) algorithms are part of a group of modeling algorithms that grasp the hidden patterns in data based on a training process, enabling them to extract complex information from the input data. In the past decade, these algorithms have been increasingly used for image processing, specifically in the medical domain. Cardiothoracic imaging is one of the early adopters of ML/DL research, and the COVID-19 pandemic resulted in more research focus on the feasibility and applications of ML/DL in cardiothoracic imaging. In this scoping review, we systematically searched available peer-reviewed medical literature on cardiothoracic imaging and quantitatively extracted key data elements in order to get a big picture of how ML/DL have been used in the rapidly evolving cardiothoracic imaging field. During this report, we provide insights on different applications of ML/DL and some nuances pertaining to this specific field of research. Finally, we provide general suggestions on how researchers can make their research more than just a proof-of-concept and move toward clinical adoption.
The Fifth International Workshop on the Evaluation and Management of Primary Hyperparathyroidism
Bilezikian, John P. , Khan, Aliya , Clarke, B.L. , Mannstadt, Michael , Potts, John T. , Clarke, Bart L , Brandi, Maria Luisa , Mannstadt, Michael , Brandi, Maria Luisa

Mayo Clinic

Journal of Bone and Mineral Research | October 17, 2022 | Volume: 37 | Issue: 11 | Pages: 2290-2292

10.1002/jbmr.4670 | PMID 36245277 Get It

A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus
Munroe, Melissa E. , Blankenship, Derek, DeFreese, Daniele C., Purushothaman, Mohan, DeJager, Wade , Macwana, Susan , Guthridge, Joel M. , Kamp, Stan, Redinger, Nancy, Aberle, Teresa, Chakravarty, Eliza F., Arriens, Cristina , Li, Yanfeng , Zeng, Hu , McCarthy-Fruin, Kathleen, Osei‐Onomahm, Shirley‐Ann, Thanarajasingam, Uma , Jupe, Eldon R. , McCarthy-Fruin, Kathleen A, James, Judith A , Zeng, Hu , Guthridge, Joel M , James, Judith A.

Mayo Clinic

Arthritis & Rheumatology | October 17, 2022 | Volume: 75 | Issue: 5 | Pages: 723-735

10.1002/art.42389 | PMID 36245261 Get It

ObjectiveSystemic lupus erythematosus (SLE) is marked by immune dysregulation linked to varied clinical disease activity. Using a unique longitudinal cohort of SLE patients, this study sought to identify optimal immune mediators informing an empirically refined flare risk index (FRI) reflecting altered immunity prior to clinical disease flare.MethodsThirty‐seven SLE‐associated plasma mediators were evaluated by microfluidic immunoassay in 46 samples obtained in SLE patients with an imminent clinical disease flare (preflare) and 53 samples obtained in SLE patients without a flare over a corresponding period (pre‐nonflare). SLE patients were selected from a unique longitudinal cohort of 106 patients with classified SLE (meeting the American College of Rheumatology 1997 revised criteria for SLE or the Systemic Lupus International Collaborating Clinics 2012 revised criteria for SLE). Autoantibody specificities, hybrid SLE Disease Activity Index (hSLEDAI) scores, clinical features, and medication usage were also compared at preflare (mean ± SD 111 ± 47 days prior to flare) versus pre‐nonflare (99 ± 21 days prior to nonflare) time points. Variable importance was determined by random forest analysis with logistic regression subsequently applied to determine the optimal number and type of analytes informing a refined FRI.ResultsPreflare versus pre‐nonflare differences were not associated with demographics, autoantibody specificities, hSLEDAI scores, clinical features, nor medication usage. Forward selection and backward elimination of mediators ranked by variable importance resulted in 17 plasma mediator candidates differentiating preflare from pre‐nonflare visits. A final combination of 11 mediators best informed a newly refined FRI, which achieved a maximum sensitivity of 97% and maximum specificity of 98% after applying decision curve analysis to define low, medium, and high FRI scores.ConclusionWe verified altered immune mediators associated with imminent disease flare, and a subset of these mediators improved the FRI to identify SLE patients at risk of imminent flare. This molecularly informed, proactive management approach could be critical in prospective clinical trials and the clinical management of lupus.
Outcomes of endoscopic retrograde cholangiography and percutaneous transhepatic biliary drainage in liver transplant recipients with a Roux-en-Y biliary-enteric anastomosis
Kohli, Divyanshoo R., Aqel, Bashar , Segaran, Nicole , Harrison, M. Edwyn , Fukami, Norio , Faigel, Douglas O. , Moss, Adyr A. , Mathur, Amit K. , Hewitt, Winston R. , Katariya, Nitin , Pannala, Rahul , Kohli, Divyanshoo Rai , Aqel, Bashar A. , Segaran, Nicole L , Moss, Adyr , Mathur, Amit , Hewitt, Winston , Harrison, M Edwyn , Faigel, Douglas O , Fukami, Norio , Katariya, Nitin N

Mayo Clinic

Annals of Hepato-Biliary-Pancreatic Surgery | October 17, 2022 | Volume: 27 | Issue: 1 | Pages: 49-55

10.14701/ahbps.22-037 | PMID 36245257 Get It

Characterization of Intercalated Cell Markers KIT and LINC01187 in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms
Mannan, Rahul , Zhang, Yuping , Chinnaiyan, Anya, Dagar, Aniket , Zelenka-Wang, Sylvia, McMurry, Lisa, Daniel, Nikita, Cao, Xuhong , Gupta, Sounak , Vaishampayan, Ulka N. , Hafez, Khaled S., Morgan, Todd M. , Spratt, Daniel E. , Tretiakova, Maria , Argani, Pedram , Mehra, Rohit , Skala, Stephanie L , Sangoi, Ankur R , Gupta, Sounak , Tretiakova, Maria S , Mehra, Rohit , Spratt, Daniel E , Morgan, Todd M , Vaishampayan, Ulka , Wang, Xiaoming , Bawa, Pushpinder , Skala, Stephanie L. , Wang, Lisha , Daniel, Nikita, Sangoi, Ankur R. , Chinnaiyan, Arul , Dhanasekaran, Saravana Mohan

Mayo Clinic

International Journal of Surgical Pathology | October 17, 2022 | Volume: 31 | Issue: 6 | Pages: 1027-1040

10.1177/10668969221125793 | PMID 36250542 Get It

Introduction. Chromophobe renal cell carcinoma (chromophobe RCC) is the third major subcategory of renal tumors after clear cell RCC and papillary RCC, accounting for approximately 5% of all RCC subtypes. Other oncocytic neoplasms seen commonly in surgical pathology practice include the eosinophilic variant of chromophobe RCC, renal oncocytoma, and low-grade oncocytic unclassified RCC. Methods. In our recent next-generation sequencing based study, we nominated a lineage-specific novel biomarker LINC01187 (long intergenic non-protein coding RNA 1187) which was found to be enriched in chromophobe RCC. Like KIT (cluster of differentiation 117; CD117), a clinically utilized chromophobe RCC related biomarker, LINC01187 is expressed in intercalated cells of the nephron. In this follow-up study, we performed KIT immunohistochemistry and LINC01187 RNA in situ hybridization (RNA-ISH) on a cohort of chromophobe RCC and other renal neoplasms, characterized the expression patterns, and quantified the expression signals of the two biomarkers in both primary and metastatic settings. Results. LINC01187, in comparison to KIT, exhibits stronger and more uniform expression within tumors while maintaining temporal and spatial consistency. LINC01187 also is devoid of intra-tumoral heterogeneous expression pattern, a phenomenon commonly noted with KIT. Conclusions. LINC01187 expression can augment the currently utilized KIT assay and help facilitate easy microscopic analyses in routine surgical pathology practice.
At Mean 30-Year Follow-Up, Cervical Spine Disease Is Common and Associated with Thoracic Hypokyphosis after Pediatric Treatment of Adolescent Idiopathic Scoliosis
Young, Ernest, Regan, Christina , Currier, Bradford L. , Yaszemski, Michael J. , Larson, A. Noelle

Mayo Clinic

Journal of Clinical Medicine | October 17, 2022 | Volume: 11 | Issue: 20 | Pages: 6064

10.3390/jcm11206064 | PMID 36294383 Get It

Patients with adolescent idiopathic scoliosis (AIS) often have reduced sagittal thoracic kyphosis (hypokyphosis) and cervical lordosis causing an uneven distribution of physiologic load. However, the long-term consequences of hypokyphosis in AIS patients have not been previously documented. To evaluate whether uneven load distribution leads to future complications in patients with AIS, we conducted a retrospective chart review and subsequently surveyed 180 patients treated for idiopathic scoliosis between 1975 and 1992. These patients all had a minimum follow-up time of 20 years since their treatment. We observed a ten-fold increase in the incidence of anterior cervical discectomy and fusion (ACDF) compared to reported rates in the non-pathologic population. Out of the 180 patients, 33 patients met the criteria and returned for follow-up radiographs. This population demonstrated a statistically significant increased rate of cervical osteoarthritis and disc degeneration. Overall, our study suggests that hypokyphosis in patients with AIS presents with increased rates of cervical spine degeneration and dysfunction, suggesting that these patients may require additional follow-up and treatment.